Press Releases
Reproducibility of Genetic Risk Factors for Long COVID Across Diverse Populations
New research published in the Journal of Translational Medicine demonstrates the reproducibility of genetic associations with long COVID across ancestrally diverse patient cohorts in the United States and United Kingdom.
This marks a significant advance in understanding the biological basis of long COVID and the development of precision diagnostics and treatments for this debilitating condition.
Solve M.E., Brain Inflammation Collaborative, ChronicleBio, Complex Disorders Alliance, and CareEvolution Launch Groundbreaking Partnership to Accelerate Research on ME/CFS, Long Covid, and IACCIs
Complex Disorders Alliance has joined forces with Solve M.E., the Brain Inflammation Collaborative (BIC), ChronicleBio, and CareEvolution to accelerate research on ME/CFS, Long Covid, and other complex chronic illnesses. Together, we are uniting data, expertise, and innovation to drive faster diagnoses, better treatments, and real breakthroughs for millions of patients worldwide.
PrecisionLife and CODA (formerly Metrodora Foundation) Announce Confirmation of Key Genetic Findings for Long COVID across Diverse Populations.
PrecisionLife and Metrodora Foundation have announced the successful reproduction of the genetic risk factors associated with long COVID across US and UK patient populations with diverse ancestries. The landmark study, leveraging PrecisionLife’s unique combinatorial analytics platform, represents a significant step forward in understanding the genetic underpinnings of long COVID and offers a strong foundation for the development of more precise diagnostic tools and therapeutic strategies, pending further clinical validation.